撤回：CD47在弥漫性大B细胞淋巴瘤（DLBCL）中的治疗策略。

4区 医学 Q3 Medicine Disease Markers Pub Date : 2023-07-12 eCollection Date: 2023-01-01 DOI:10.1155/2023/9826727
Disease Markers
{"title":"撤回：CD47在弥漫性大B细胞淋巴瘤（DLBCL）中的治疗策略。","authors":"Disease Markers","doi":"10.1155/2023/9826727","DOIUrl":null,"url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/4894022.].</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"9826727"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356524/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).\",\"authors\":\"Disease Markers\",\"doi\":\"10.1155/2023/9826727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This retracts the article DOI: 10.1155/2021/4894022.].</p>\",\"PeriodicalId\":11201,\"journal\":{\"name\":\"Disease Markers\",\"volume\":\"2023 \",\"pages\":\"9826727\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356524/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Disease Markers\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/9826727\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Disease Markers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/9826727","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

[这收回了文章DOI:10.1155/2021/4894022.]。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).

[This retracts the article DOI: 10.1155/2021/4894022.].

求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
Disease Markers
Disease Markers 医学-病理学
自引率
0.00%
发文量
792
审稿时长
6-12 weeks
期刊介绍： Disease Markers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.
期刊最新文献
Impact of rs599839 Polymorphism on Coronary Artery Disease Risk in Saudi Diabetic Patients. Corrigendum to "Fluvastatin Upregulates the α 1C Subunit of CaV1.2 Channel Expression in Vascular Smooth Muscle Cells via RhoA and ERK/p38 MAPK Pathways". JAK2 as Predictor of Therapeutic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1